ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.
Lung Cancer Gets Less Press, Study Finds
Vanderbilt Wins Lung Cancer SPORE Grant.
Vanderbilt, Jonsson Centers Win NCI SPORE Grants.
Prevention Trials Should Get More Funding, Coltman Says.
FDA Approves Gleevec In 73 Days, A Speed Record.
Pesticides Not Linked To High Rates Of Breast Cancer.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- No need for a speculum? A new era of HPV screening
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally









